OPLAH
protein-coding5-oxoprolinase, ATP-hydrolysing, the group of MicroRNA protein coding host genes
Gene summary
The protein encoded by this gene acts as a homodimer, using ATP hydrolysis to catalyze the conversion of 5-oxo-L-proline to L-glutamate. Defects in this gene are a cause of 5-oxoprolinase deficiency (OPLAHD). [provided by RefSeq, Jun 2012]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~12.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009825
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009825
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009825
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Gastrointestinal; Renal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Transient neonatal hypoglycemia has been reported
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to OPLAH variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017570.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 109 | 11 | 127 | ||
| missense | 1 | 4 | 311 | 26 | 13 | 355 |
| nonsense | 8 | 8 | 2 | 18 | ||
| start loss | 0 | |||||
| frameshift | 11 | 9 | 3 | 23 | ||
| splice donor/acceptor (+/-2bp) | 1 | 6 | 7 | 14 | ||
| Total | 21 | 27 | 330 | 135 | 24 | 537 |
Highest pathogenic variant AF is 0.00006299282
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060040.1 | 26 | MANE Select | |
| Ensembl | ENSP00000480476.1 | 26 | MANE Select | |
| Ensembl | ENSP00000481640.2 | 5 | Standard | |
| Ensembl | ENSP00000565012.1 | 26 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glutathione metabolism - Homo sapiens (human)
- Gamma-glutamyl-transpeptidase deficiency
- 5-oxoprolinase deficiency
- Gamma-Glutamyltransferase Deficiency
- Glutathione Metabolism
Biological Process
- glutathione metabolic process
- glutathione biosynthetic process
Molecular Function
- ATP binding
- 5-oxoprolinase (ATP-hydrolyzing) activity
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000426825
- Coding exons
- 27
- Length
- 12569
- Individuals with no LoFs
- 19252
- Homozygous LoFs
- 105234
- Heterozygous LoFs
- 34
- Defined
- 124520
- p
- 0.607
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.265 | 816 | 838 | 0.974 | 0.0000570 | 8098 |
| Missense (PolyPhen) | 328 | 369.13 | 0.88857 | 3532 | ||
| Synonymous | -0.0242 | 368 | 367 | 1.00 | 0.0000260 | 2807 |
| Loss of Function | 2.33 | 34 | 52.2 | 0.652 | 0.00000272 | 559 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 1.0 | 0.49 | notable |
| Latino/Admixed American | 1.0 | 0.80 | notable |
| Ashkenazi Jewish | 1.0 | 0.69 | notable |
| East Asian | 1.0 | 0.69 | notable |
| Finnish | 1.0 | 0.30 | notable |
| European (Non-Finnish) | 1.0 | 0.60 | notable |
| South Asian | 1.0 | 0.79 | notable |
| Other | 1.0 | 0.65 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the cleavage of 5-oxo-L-proline to form L- glutamate coupled to the hydrolysis of ATP to ADP and inorganic phosphate.;
- Disease
- DISEASE: 5-oxoprolinase deficiency (OPLAHD) [MIM:260005]: A disorder characterized by calcium oxalate/carbonate urolithiasis, and excessive urinary 5-oxo-L-proline. Affected individuals have recurrent episodes of vomiting, diarrhea, and abdominal pain. {ECO:0000269|PubMed:21651516}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.186
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |